CCM
Camber Capital Management Portfolio holdings
AUM
$718M
This Quarter Return
+0.38%
1 Year Return
-4.23%
3 Year Return
+26.63%
5 Year Return
+47.71%
10 Year Return
+121.3%
AUM
$1.2B
AUM Growth
+$1.2B
(-27%)
Cap. Flow
-$447M
Cap. Flow
% of AUM
-37.24%
Top 10 Holdings %
Top 10 Hldgs %
66.39%
Holding
36
New
4
Increased
6
Reduced
7
Closed
13
Top Buys
| 1 |
Perrigo
PRGO
|
$82.5M |
| 2 |
HCA Healthcare
HCA
|
$63.7M |
| 3 |
EVHC
Envision Healthcare Holdings Inc
EVHC
|
$51.7M |
| 4 |
TSRO
TESARO, Inc.
TSRO
|
$51.6M |
| 5 |
RDUS
Radius Health, Inc.
RDUS
|
$40.5M |
Top Sells
| 1 |
Teva Pharmaceuticals
TEVA
|
$175M |
| 2 |
Gilead Sciences
GILD
|
$122M |
| 3 |
AGN
Allergan plc
AGN
|
$85.1M |
| 4 |
Select Medical
SEM
|
$76.8M |
| 5 |
Viatris
VTRS
|
$48.5M |
Sector Composition
| 1 | Healthcare | 80.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Nektar Therapeutics
NKTR
$568M
| $125M | 7.91% | 5,200,000 -150,000 | -3% | -$3.6M |
|
2
Tenet Healthcare
THC
$16.3B
| $94.5M | 5.99% | 5,750,000 +1,750,000 | +44% | +$28.8M |
|
|
3
Viatris
VTRS
$12.3B
| $84.7M | 5.37% | 2,700,000 -1,545,889 | -36% | -$48.5M |
|
|
4
Perrigo
PRGO
$3.27B
| $82.5M | 5.23% | +975,000 | New | +$82.5M |
|
|
GHDX
5
DELISTED
Genomic Health, Inc.
GHDX
| $78.9M | 5% | 2,458,100 | – | – |
|
6
Myriad Genetics
MYGN
$593M
| $72.4M | 4.59% | 2,000,000 -1,000,000 | -33% | -$36.2M |
|
|
EVHC
7
DELISTED
Envision Healthcare Holdings Inc
EVHC
| $67.4M | 4.27% | 1,500,000 +1,150,000 | +329% | +$51.7M |
|
8
Orthofix Medical
OFIX
$592M
| $65M | 4.12% | 1,375,000 -125,000 | -8% | -$5.91M |
|
|
9
HCA Healthcare
HCA
$94.5B
| $63.7M | 4.04% | +800,000 | New | +$63.7M |
|
10
Sarepta Therapeutics
SRPT
$1.78B
| $63.5M | 4.02% | 1,400,000 +100,000 | +8% | +$4.54M |
|
11
Brookdale Senior Living
BKD
$1.83B
| $57.2M | 3.63% | 5,400,000 | – | – |
|
|
BIVV
12
DELISTED
Bioverativ Inc. Common Stock
BIVV
| $57.1M | 3.62% | 1,000,000 -174,300 | -15% | -$9.95M |
|
|
TSRO
13
DELISTED
TESARO, Inc.
TSRO
| $51.6M | 3.27% | +400,000 | New | +$51.6M |
|
|
AMAG
14
DELISTED
AMAG Pharmaceuticals, Inc.
AMAG
| $48.9M | 3.1% | 2,650,000 +950,000 | +56% | +$17.5M |
|
|
RDUS
15
DELISTED
Radius Health, Inc.
RDUS
| $44.3M | 2.81% | 1,150,000 +1,050,000 | +1,050% | +$40.5M |
|
|
16
Gilead Sciences
GILD
$140B
| $40.5M | 2.57% | 500,000 -1,500,000 | -75% | -$122M |
|
|
ELGX
17
DELISTED
Endologix Inc
ELGX
| $35.7M | 2.26% | 8,000,000 +500,000 | +7% | +$2.23M |
|
|
NVTA
18
DELISTED
Invitae Corporation
NVTA
| $22.5M | 1.42% | 2,398,123 | – | – |
|
19
Option Care Health
OPCH
$4.65B
| $17.3M | 1.1% | 6,300,200 -3,879,800 | -38% | -$10.7M |
|
|
CLVS
20
DELISTED
Clovis Oncology, Inc.
CLVS
| $16.5M | 1.04% | +200,000 | New | +$16.5M |
|
21
Atara Biotherapeutics
ATRA
$84.6M
| $8.86M | 0.56% | 535,500 | – | – |
|
|
BIOL
22
DELISTED
Biolase, Inc.
BIOL
| $3.21M | 0.2% | 5,332,394 | – | – |
|
23
Biogen
BIIB
$19.4B
| – | – | -100,000 | Closed | -$27.1M |
|
24
PTC Therapeutics
PTCT
$3.92B
| – | – | -500,000 | Closed | -$9.17M |
|
|
25
Select Medical
SEM
$1.61B
| – | – | -5,000,000 | Closed | -$76.8M |
|